Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Combining antidepressants to hasten remission from depression

Trial Profile

Combining antidepressants to hasten remission from depression

Phase of Trial: Phase IV

Latest Information Update: 07 Oct 2017

At a glance

  • Drugs Bupropion (Primary) ; Escitalopram (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 26 Jun 2012 Additional lead trial centre(National Institute of Mental Health (NIMH)) identified as reported by ClinicalTrials.gov.
    • 26 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top